GLOBAL RESEARCH ARCHIVE
Reminder: Expert Access: Barclays KOL call *Today*: Injectable Aesthetics market dynamics and emerging innovations (Reads to GALD, IPN, ABBV)
Research evidence excerpt
Reminder: Expert Access: Barclays KOL call *Today*: Injectable Aesthetics market dynamics and emerging innovations (Reads to GALD, IPN, ABBV)
Meet the Speakers
Michelle Ehrlich, MD, is a Dermatologist and Cosmetic Surgeon in private practice at
Dermatology and Laser Center in Manhattan Beach, CA. She also serves as Director of
Cosmetic Dermatology and Surgery for the Harbor-UCLA residency program and a Clinical
Instructor in Dermatology at UCLA. She is board-certified in dermatology. She is an expert
in the landscape and trajectory of the professional skincare industry. Her areas of expertise
include dermal fillers (Botox, Restylane, Hylaform, Sculptra, and collagen) and other
wrinkle smoothing treatments; anti-aging laser treatments; minimally invasive facelift and
facelift alternatives; liposculpture and liposuction; body contouring; treatment of leg veins;
photorejuvenation and photodynamic therapy; adult acne and acne scar treatments; and
laser hair removal and tattoo removal, among other procedures. An experienced
researcher, she is a published author in scientific journals and textbooks. She is a Diplomat
of the American Board of Dermatology and a Fellow of the American Academy of Cosmetic
Surgery. She completed her advanced fellowship in cosmetic surgery, laser, and cosmetic
dermatology at the La Jolla SpaMD, where she trained with a team of cosmetic
dermatologists, facial plastic surgeons, and general plastic and reconstructive surgeons.
Previously, she completed her training in dermatology and internal medicine at the
Cleveland Clinic Foundation.
Meet the Analysts
Yihan Li, PhD, is a Vice President in the European
Pharmaceuticals team at Barclays. She joined Barclays
and moved to London in 2025, prior to which she worked
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer